Join the #HERDanceParty! Dance, Invite, and Donate to improve HG care through research and education.
April 2, 2022, is World Autism Awareness Day. At the HER Foundation, we light up kindness and wear blue in support of understanding and acceptance for people with autism. Children born after an HG pregnancy have an increased risk of an autism diagnosis, and we are grateful for each of these children.
While some medications target vomiting (ondansetron/Zofran), there are no medications that specifically target nausea. Some medications used to treat Hyperemesis Gravidarum (HG) may help reduce nausea but rarely will medications eliminate all nausea. Since there are numerous causes of nausea, treating as many as possible is most effective. This list of strategies may help reduce nausea depending on what is triggering symptoms. None works for everyone, but each may help a little.
I knew nearly nothing about hyperemesis, even after my ER diagnosis. The HER website helped educate me about symptoms and how to approach medical professionals. HER helped alleviate some concerns about medications.
Overall, this study contributes to our understanding of the biology of nausea and vomiting in pregnancy and may lead to future research evaluating new treatment avenues. Of note, drugs targeting the GDF15 pathway have shown great promise in mitigating weight loss, loss of appetite, and vomiting in animal models and are currently in clinical trials in cancer cachexia, a disease with similar symptoms to HG.
Hyperemesis Gravidarum (HG) is not self-limiting, and its impact can last a lifetime for mothers and their children. Until there is recognition of this fact and comprehensive, universal, effective treatment for all HG patients, every level of society will continue to face the costs of HG.
February is Heart Health Month, and the HER Foundation shares 4 ways for you to protect your heart.
May 15th is International HG Awareness Day and HG Reality. You can help the HER Foundation raise awareness and educate about your HG Reality!
Dr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Be a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
